PEDEVCO CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data PEDEVCO CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue		3.02	4.52	13	8.06	15.9	30.8	30.8	39.6	45.8
Selling, general and administrative	3.91	2.53	4.14	5.79	6.74	6.21	5.85	6.01	6.39	16.8
Operating expenses	9.63	26.6	13.5	24.2	41.9	19.5	27.4	25.3	34.8	54.8
Operating income	-5.66	-23.6	-9	-10.2	-33.8	-1.87	2.63	1.24	4.72	-7.86
Interest expense	14	12.8	7.7	0.82	0	0	0		0	1.41
Interest income			0	0.06	0.04	0.02	0.12	0.42	0.35	0.27
Other non-operating income	-14	-12.8	62.6	-0.88	1.13	0.57	0.21	0.46	0.32	5.55
Pre-tax income								1.7	5.04	-2.31
Income tax					0	0		0	-7.26	8.06
Net income to minority interests	0
Net income	-19.6	-36.4	53.6	-11.1	-32.7	-1.3	2.84	1.7	12.3	-10.4
EBITDA	-0.58	-19.8	-1.68	0.8	-22.5	5.51	13.8	12.1	20.6	10.2
EPS, basic	-79.25	-122.62	94.63	-4.34	-8.87	-0.39	0.59	0.39	2.76	-2.25
EPS, diluted	-79.25	-122.62	93.45	-4.34	-8.87	-0.39	0.59	0.39	2.76	-2.25
Shares, basic (weighted)	0.25	0.3	0.57	2.6	0	4.06	4.34	4.41	4.46	4.62
Shares, diluted (weighted)	0.25	0.3	0.57	2.6	3.66	4.06	4.34	4.41	4.46	4.62

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	0.66	0.92	3.46	22.4	8.03	25.9	29.4	18.5	4.01	3.22
Receivables							0	0.04	0.29	25.7
Inventory									0	0.06
Other current assets	0.17	0.18	0.2	0.07	0.07	0.33	0.25	0.26	0.92	0.43
Total current assets	1.3	1.39	6.83	27.1	8.75	28	32.1	24.6	13.2	37.8
Lease right-of-use assets			0	0.36	0.27	0.17	0.07	0.32	0.22	0.21
Other non-current assets	0.09	0.09	0.24	3.6	3.54	3.54	3.78	2.44	3.21
Total assets	58.8	36.4	67.5	123	79.6	98.2	116	123	128	376
Accounts payable	0.1	0.1	4.51	12.1	0.21	2.63	1.56	6.58	2.63	32.4
Accrued liabilities	1.8	2.13	3.39	1.97	0.3	1.45	13.8	8.71	2.26	8.25
Total current liabilities	3.31	3.37	8.85	15.2	1.98	5.18	17	18.9	6.91	64.5
Long-term debt	27.5	34.2	0
Lease liabilities			0	0.3	0.2	0.08	0	0.23	0.13	0.03
Other non-current liabilities										2.2
Total liabilities	60.7	73.5	50.6	15.2	3.93	6.74	19.7	21.3	12.7	169
Total debt			7.69	0
Paid-in capital	99.8	101	101	201	204	221	223	225	227	312
Retained earnings	-102	-138	-84.5	-95.6	-128	-130	-127	-124	-111	-122
Shareholders' equity	-1.96	-37.1	17	106	75.6	91.5	97.7	101	116	207
Minority interests	0	0
Total equity	-1.96	-37.1	17	106	75.6	91.5	97.7	101	116	207
Total liabilities and equity	58.8	36.4	67.5	123	79.6	98.2	116	123	128	376
Shares outstanding	0.28	0.37	0.8	3.6	3.68	4.27	4.35	4.43	4.47	4.8

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-19.6	-36.4	52.8	-11.1	-32.7	-1.3	2.84	1.7	12.3	-10.4
Depreciation and amortization	5.08	3.75	7.33	11	11.3	7.38	11.2	10.9	15.9	18
Stock-based compensation	1.48	0.66	0.86	1.56	2.82	2.45	2.1	2.04	1.86	2.76
Deferred income tax								0	-7.26	8.06
Change in receivables	0.56	0.14	-0.54	-3.76	-3.94	1.12	-0.65	-3.36	-2.12	-4.98
Change in inventory									0	-0.06
Change in payables	-3.28	-0	0.41	5.41	-3.2	-0.36	-0.16	-0.01	0.54	2.31
Cash from operations	-5.97	-0.24	-1.49	1.67	0.01	5.97	16	23.5	12.8	10.8
Capital expenditures		0	-3.27				0	-0.05
Cash from investing	-0.08	0	-23.1	-39.7	-14.8	-2.76	-12.3	-35.7	-26.9	-133
Debt repaid				0	-0.37	0
Stock issued	0	0.53	0	43	0	14.7	0.04	0	0	0.14
Share buybacks	-0.07	0
Cash from financing	5.57	0.49	29.5	58	0.37	14.7	0.04	0	0	122
Net change in cash					-14.4	17.9	3.75	-12.3	-14.1	-0.29
Free cash flow		-0.24	-4.76				16	23.4
Interest paid	0.55	0	0	0	0	0	0	0	0	0.59
Income taxes paid	0	0	0	0	0	0	0	0	0	0

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $13.11 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	14.0%	Operating income / revenue.
EBITDA margin	42.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-7.2%	Pre-tax income / revenue.
Net margin	-14.6%	Net income / revenue.
Operating cash flow margin	26.7%	Cash from operations / revenue.
Return on equity (ROE)	-8.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-4.7%	Net income / average total assets.
Return on invested capital (ROIC)	6.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	17.2%	Selling, general and administrative expense / revenue.
D&A / revenue	28.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	15.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	14.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	41.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-266.5%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-50.8%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-9.7%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	-184.3%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-181.5%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-15.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-12.4%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	289.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	79.4%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	28.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	22.3%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	192.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	47.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	36.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	3.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	2.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	4.7%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.78x	Current assets / current liabilities.
Quick ratio	0.69x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.21x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	44.4%	Total liabilities / total assets.
Interest coverage	3.03x	Operating income / interest expense.
Working capital	-$10.9M	Current assets - current liabilities.
Tangible book value	$200.1M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.32x	Revenue / average total assets.
Receivables turnover	4.85x	Revenue / average receivables.
Days sales outstanding	75 days	365 x average receivables / revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$1.28	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$8.75	Revenue / diluted weighted shares.
Operating cash flow per share	$2.34	Cash from operations / diluted weighted shares.
Book value per share	$15.05	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$15.05	Tangible book value / shares outstanding.
Cash per share	$0.81	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$174.2M	Share price x shares outstanding.
Enterprise value	$163.4M	Market cap + total debt - cash - short-term investments.
P/S	1.50x	Market cap / revenue.
P/B	0.87x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.87x	Market cap / tangible book value, when positive.
P/OCF	5.60x	Market cap / cash from operations, when positive.
EV/Sales	1.40x	Enterprise value / revenue.
EV/EBIT	10.0x	Enterprise value / operating income, when both are positive.
EV/EBITDA	3.29x	Enterprise value / EBITDA, when both are positive.
Earnings yield	-9.8%	Net income / market cap (the inverse of P/E).

What was PEDEVCO CORP's revenue in fiscal 2025?

PEDEVCO CORP reported revenue of $45.8M for fiscal 2025, 15.7% higher than the year before.

Was PEDEVCO CORP profitable in fiscal 2025?

No. It reported a net loss of $10.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to PEDEVCO CORP